Alan Gilbert Goodman
Directeur Général chez Avlar Ltd.
Profil
Mr. Alan G.
Goodman is a Chief Executive Officer & Finance Director at Avlar Ltd.
Mr. Goodman was previously employed as a Non-Executive Director by Alizyme Plc, a Member-Supervisory Board by PAION AG, a Chairman by CeNeS Pharmaceuticals Plc, a Principal by Amura Ltd., a Principal by Acambis Plc, a Non-Executive Director by Amura Holdings Ltd., a Principal by Chiroscience Group Plc, a Principal by Core Group Ltd., a Non-Executive Director by Crescendo Biologics Ltd., a Principal by Medeva Plc, a Principal by Oxford Biomedica Plc, a Non-Executive Director by Paradigm Therapeutics Ltd., a Chairman by Proteom Ltd., and a Principal by The MicroBio Group Ltd.
Postes actifs de Alan Gilbert Goodman
| Sociétés | Poste | Début |
|---|---|---|
Avlar Ltd.
 Avlar Ltd. Investment ManagersFinance Avlar Ltd. (Avlar BioVentures) is a venture capital firm founded in 1999 by Alan Goodman and Daniel Roach. The firm is headquartered in Cambridge, United Kingdom. | Directeur Général | 01/01/1999 |
Anciens postes connus de Alan Gilbert Goodman
| Sociétés | Poste | Fin |
|---|---|---|
| PAION AG | Directeur/Membre du Conseil | 21/05/2014 |
Amura Ltd.
 Amura Ltd. Pharmaceuticals: MajorHealth Technology Amura Ltd. manufactured, fabricated and processed drugs in pharmaceutical preparations. It offered drugs for human or veterinary use. The company was founded in 1996 and was headquartered in Cambridge, the United Kingdom. | Fondateur | 26/08/2012 |
Core Group Ltd.
 Core Group Ltd. Finance/Rental/LeasingFinance Core Group Ltd. provides construction equipment rental services. The private company is based in Halesowen, UK. The British company was founded by Alan Gilbert Goodman. | Fondateur | - |
| OXFORD BIOMEDICA PLC | Fondateur | - |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PAION AG | Health Technology |
| OXFORD BIOMEDICA PLC | Health Technology |
| Entreprise privées | 13 |
|---|---|
CeNeS Pharmaceuticals Plc
 CeNeS Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals Plc engages in the discovery and development of drugs. The company was founded by Alan Gilbert Goodman in 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
Alizyme Plc
 Alizyme Plc Pharmaceuticals: MajorHealth Technology Alizyme Plc was engaged in the development of pharmaceutical products for the diseases related to obesity treatment. The company was founded in 1995 and was headquartered in Cambridge, the United Kingdom. | Health Technology |
Avlar Ltd.
Avlar Ltd. Investment ManagersFinance Avlar Ltd. (Avlar BioVentures) is a venture capital firm founded in 1999 by Alan Goodman and Daniel Roach. The firm is headquartered in Cambridge, United Kingdom. | Finance |
| Medeva Plc | Health Technology |
The MicroBio Group Ltd.
 The MicroBio Group Ltd. Chemicals: AgriculturalProcess Industries Microbio Group Ltd. manufactures organic fertilizers and crop protection products. The company is headquartered in Littlehampton, GB. | Process Industries |
| Chiroscience Group Plc | Commercial Services |
Paradigm Therapeutics Ltd.
 Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK. | Health Technology |
Proteom Ltd.
 Proteom Ltd. Pharmaceuticals: MajorHealth Technology Proteom Ltd. used to develop pharmaceutical products. It had created computational chemistry platform to help identify and screen novel small molecule and peptide based ligands for protein targets. Proteom's ProtoBuild used to provide silico (computer-simulated) design and its ProtoScreen used to identify potential leads from a variety of commercially available compounds. Proteom Ltd. was headquartered in Comberton, EA. | Health Technology |
Amura Holdings Ltd.
 Amura Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amura Holdings Ltd. was engaged in drug discovery for diseases, such as osteoporosis, osteoarthritis, bone metastasis, autoimmunity, chronic pain, and malaria. The firm developed a technology platform that provided turnkey solutions for the discovery of small-molecule inhibitors against cysteine peptidases. The company was founded by Daniel James William Roach on June 6, 20005 and was headquartered in Cambridge, the United Kingdom. | Health Technology |
Core Group Ltd.
Core Group Ltd. Finance/Rental/LeasingFinance Core Group Ltd. provides construction equipment rental services. The private company is based in Halesowen, UK. The British company was founded by Alan Gilbert Goodman. | Finance |
Amura Ltd.
Amura Ltd. Pharmaceuticals: MajorHealth Technology Amura Ltd. manufactured, fabricated and processed drugs in pharmaceutical preparations. It offered drugs for human or veterinary use. The company was founded in 1996 and was headquartered in Cambridge, the United Kingdom. | Health Technology |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |